Output From the National MDS Study: Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies From Other Cytopenic Conditions

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Johns Hopkins

2023 Updates in Gastrointestinal Cancers
Videos
Events

Playback speed

10 seconds

Output From the National MDS Study: Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies From Other Cytopenic Conditions

By Johns Hopkins FEATURING Amy DeZern

205 views

June 7, 2023

Comments 0

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Videos

New

Impact of Neoadjuvant IO on Recurrence-Free Survival in High-Risk Lo…

Johns Hopkins

M. Nakazawa

42 views

ASCO® 2024 Summary: "Treatment Strategies and QoL Impact in mCRPC - …

2024 ASCO® Annual Meeting Insights Hub

C. Paller

170 views

Current Evidence for Frontline Systematic Treatment in Advanced HCC

Johns Hopkins

M. Baretti

272 views

ASH 2023 Insights: "A Comparison of HMAs Combined With Ivosidenib or…

Insights from 2023 ASH Annual Meeting

A. Ambinder

50 views

Output From the National MDS Study: Utility of Targeted Gene Sequenc…

Johns Hopkins

A. DeZern

205 views

Targeting BRAF-Altered Glioma in Adults

Johns Hopkins

K. Schreck

454 views

Severe Aplastic Anemia: What's on the Horizon?

Johns Hopkins

A. DeZern

557 views

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Johns Hopkins

M. Yarchoan

670 views

Latest Treatment Strategies and Standard of Care for Pancreatic Canc…

MedNews Week

M. Pishvaian

629 views

KRASG12C Mutation in NSCLC: Current Data and Future Directions

Johns Hopkins

S. Rosner

448 views